نتایج جستجو برای: pharmacogenetics studies

تعداد نتایج: 1428278  

Journal: :Pharmacological reviews 2011
Qiang Ma Anthony Y H Lu

Individual variability in drug efficacy and drug safety is a major challenge in current clinical practice, drug development, and drug regulation. For more than 5 decades, studies of pharmacogenetics have provided ample examples of causal relations between genotypes and drug response to account for phenotypic variations of clinical importance in drug therapy. The convergence of pharmacogenetics ...

2015
Guohai Chen Radouil Tzekov Wensheng Li Fangzheng Jiang Sihong Mao Yuhua Tong

The purpose of this study is to investigate whether the Y402H polymorphism (rs1061170, a T-to-C transition at amino acid position 402) in the complement factor H (CFH) gene have a pharmacogenetics effect on the anti-vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular degeneration (AMD). We performed a meta-analysis using databases including PubMed and EMBASE ...

Journal: :Trends in molecular medicine 2001
B B Spear M Heath-Chiozzi J Huff

Pharmacogenetics encompasses the involvement of genes in an individual's response to drugs. As such, the field covers a vast area including basic drug discovery research, the genetic basis of pharmacokinetics and pharmacodynamics, new drug development, patient genetic testing and clinical patient management. Ultimately, the goal of pharmacogenetics is to predict a patient's genetic response to ...

Journal: :International journal of oncology 2012
Alessandro Martino Juan Sainz Gabriele Buda Krzysztof Jamroziak Rui Manuel Reis Ramón García-Sanz Manuel Jurado Rafael Ríos Zofia Szemraj-Rogucka Herlander Marques Fabienne Lesueur Victor Moreno Enrico Orciuolo Federica Gemignani Stefano Landi Anna Maria Rossi Charles Dumontet Mario Petrini Daniele Campa Federico Canzian

There is strong evidence suggesting the presence of a genetic component in the aetiology of multiple myeloma (MM). However no genetic risk factors have been unequivocally established so far. To further our understanding of the genetic determinants of MM risk, a promising strategy is to collect a large set of patients in a consortium, as successful...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2000
D W Hein C A McQueen D M Grant G H Goodfellow F F Kadlubar W W Weber

This article is a report on a symposium sponsored by the American Society for Pharmacology and Experimental Therapeutics presented at the joint meeting of the American Society for Biochemistry and Molecular Biology and the American Society for Pharmacology and Experimental Therapeutics, June 4-8, Boston, Massachusetts. The presentations focused on the pharmacogenetics of the NAT1 and NAT2 aryla...

Journal: :Respiratory Research 2002
Ian P Hall

The availability of a draft sequence for the human genome will revolutionise research into airway disease. This review deals with two of the most important areas impinging on the treatment of patients: pharmacogenetics and pharmacogenomics. Considerable inter-individual variation exists at the DNA level in targets for medication, and variability in response to treatment may, in part, be determi...

Journal: :Clinical pharmacology and therapeutics 2011
J J Swen M Nijenhuis A de Boer L Grandia A H Maitland-van der Zee H Mulder G A P J M Rongen R H N van Schaik T Schalekamp D J Touw J van der Weide B Wilffert V H M Deneer H-J Guchelaar

Currently, there are very few guidelines linking the results of pharmacogenetic tests to specific therapeutic recommendations. Therefore, the Royal Dutch Association for the Advancement of Pharmacy established the Pharmacogenetics Working Group with the objective of developing pharmacogenetics-based therapeutic (dose) recommendations. After systematic review of the literature, recommendations w...

2017
Devang M. Desai

When one discusses pharmacogenetics in cardiology practice, it is almost obligatory to discuss clopidogrel. Clopidogrel is an antiplatelet used for acute coronary syndrome (ACS), percutaneous coronary intervention (PCI) with stenting, and as secondary stroke prevention in patients with aspirin allergy, among other indications. Clopidogrel is a prodrug that must be metabolized through the cytoch...

Journal: :Clinical pharmacology and therapeutics 2008
A C Wu A L Fuhlbrigge

Ever since the sequencing of the human genome was completed, prediction of treatment response in terms of genetic variation has been seen as an important and achievable goal. Pharmacogenetics is the study of how genetic differences affect variation in response to medication. One potential goal of pharmacogenetics is to be able to deliver "personalized medicine" by making management decisions th...

2009
Aneesh T P Sonal Sekhar M Asha Jose Lekshmi Chandran Subin Mary Zachariah

UNLABELLED Pharmacogenomics is the branch of pharmacology which deals with the influence of genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with a drug's efficacy or toxicity. It aims to develop rational means to optimize drug therapy, with respect to the patients genotype, to ensure maximum efficacy with minimal adverse effects. ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید